Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement
Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR). The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry....
Saved in:
Published in | Journal of the American College of Cardiology Vol. 71; no. 14; pp. 1513 - 1524 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
10.04.2018
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0735-1097 1558-3597 1558-3597 |
DOI | 10.1016/j.jacc.2018.01.066 |
Cover
Abstract | Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).
The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.
Data were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.
During the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).
DCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected.
[Display omitted] |
---|---|
AbstractList | Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).
The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.
Data were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.
During the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).
DCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected. Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR). The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry. Data were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016. During the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09). DCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected. [Display omitted] BackgroundDelayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).ObjectivesThe aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.MethodsData were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.ResultsDuring the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).ConclusionsDCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected. Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).BACKGROUNDDelayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.OBJECTIVESThe aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.Data were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.METHODSData were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.During the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).RESULTSDuring the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).DCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected.CONCLUSIONSDCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected. AbstractBackgroundDelayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR). ObjectivesThe aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry. MethodsData were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016. ResultsDuring the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09). ConclusionsDCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected. |
Author | de Backer, Ole Tchetche, Didier Rodés-Cabau, Josep Sievert, Horst Gatto, Pamela Barbanti, Marco Scholtz, Smita Dvir, Danny Butter, Christian Søndergaard, Lars Webb, John Colombo, Antonio Alfieri, Ottavio Tamburino, Corrado Sinning, Jan Malte Scholtz, Werner Abdel-Wahab, Mohamed Jabbour, Richard J. Rahhab, Zouhair Finkelstein, Ariel Mack, Michael Latib, Azeem Stundl, Anja Purita, Paola Testa, Luca Tanaka, Akihito Tarantini, Giuseppe Van Mieghem, Nicolas Szerlip, Molly Castriota, Fausto Veulemans, Verena Nerla, Roberto |
Author_xml | – sequence: 1 givenname: Richard J. surname: Jabbour fullname: Jabbour, Richard J. organization: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy – sequence: 2 givenname: Akihito surname: Tanaka fullname: Tanaka, Akihito organization: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy – sequence: 3 givenname: Ariel surname: Finkelstein fullname: Finkelstein, Ariel organization: Interventional Cardiology, Tel-Aviv Medical Center, Tel-Aviv, Israel – sequence: 4 givenname: Michael surname: Mack fullname: Mack, Michael organization: The Heart Hospital Baylor Plano, Plano, Texas – sequence: 5 givenname: Corrado surname: Tamburino fullname: Tamburino, Corrado organization: Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy – sequence: 6 givenname: Nicolas surname: Van Mieghem fullname: Van Mieghem, Nicolas organization: Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 7 givenname: Ole surname: de Backer fullname: de Backer, Ole organization: Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark – sequence: 8 givenname: Luca surname: Testa fullname: Testa, Luca organization: Department of Cardiology, IRCCS Pol. San Donato, Milan, Italy – sequence: 9 givenname: Pamela surname: Gatto fullname: Gatto, Pamela organization: Clinique Pasteur, Toulouse, France – sequence: 10 givenname: Paola surname: Purita fullname: Purita, Paola organization: Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy – sequence: 11 givenname: Zouhair surname: Rahhab fullname: Rahhab, Zouhair organization: Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands – sequence: 12 givenname: Verena surname: Veulemans fullname: Veulemans, Verena organization: Department of Cardiology, Pulmonology, and Angiology, University Hospital, Düsseldorf, Germany – sequence: 13 givenname: Anja surname: Stundl fullname: Stundl, Anja organization: Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany – sequence: 14 givenname: Marco surname: Barbanti fullname: Barbanti, Marco organization: Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy – sequence: 15 givenname: Roberto surname: Nerla fullname: Nerla, Roberto organization: Interventional Cardiology Unit, GVM Maria Cecilia Hospital, Cotignola, Italy – sequence: 16 givenname: Jan Malte surname: Sinning fullname: Sinning, Jan Malte organization: Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany – sequence: 17 givenname: Danny surname: Dvir fullname: Dvir, Danny organization: Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 18 givenname: Giuseppe surname: Tarantini fullname: Tarantini, Giuseppe organization: Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy – sequence: 19 givenname: Molly surname: Szerlip fullname: Szerlip, Molly organization: The Heart Hospital Baylor Plano, Plano, Texas – sequence: 20 givenname: Werner surname: Scholtz fullname: Scholtz, Werner organization: Department of Cardiology, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Oeynhausen, Germany – sequence: 21 givenname: Smita surname: Scholtz fullname: Scholtz, Smita organization: Department of Cardiology, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Oeynhausen, Germany – sequence: 22 givenname: Didier surname: Tchetche fullname: Tchetche, Didier organization: Clinique Pasteur, Toulouse, France – sequence: 23 givenname: Fausto surname: Castriota fullname: Castriota, Fausto organization: Interventional Cardiology Unit, GVM Maria Cecilia Hospital, Cotignola, Italy – sequence: 24 givenname: Christian surname: Butter fullname: Butter, Christian organization: Department of Cardiology, Heart Center Brandenburg, Bernau bei Berlin, Germany – sequence: 25 givenname: Lars surname: Søndergaard fullname: Søndergaard, Lars organization: Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark – sequence: 26 givenname: Mohamed surname: Abdel-Wahab fullname: Abdel-Wahab, Mohamed organization: Heart Center, Segeberger Kliniken GmbH, Academic Teaching Hospital of the Universities of Kiel, Lübeck and Hamburg, Bad Segeberg, Germany – sequence: 27 givenname: Horst surname: Sievert fullname: Sievert, Horst organization: CardioVascular Center Frankfurt CVC, Sankt Katharinen Krankenhaus, Frankfurt, Germany – sequence: 28 givenname: Ottavio surname: Alfieri fullname: Alfieri, Ottavio organization: Cardiothoracic Unit, San Raffaele Scientific Institute, Milan, Italy – sequence: 29 givenname: John surname: Webb fullname: Webb, John organization: Department of Medical Imaging and Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 30 givenname: Josep surname: Rodés-Cabau fullname: Rodés-Cabau, Josep organization: Quebec Heart and Lung Institute, Quebec City, Quebec, Canada – sequence: 31 givenname: Antonio surname: Colombo fullname: Colombo, Antonio organization: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy – sequence: 32 givenname: Azeem surname: Latib fullname: Latib, Azeem email: alatib@gmail.com organization: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29622157$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl2L1DAUhoOsuLOjf8ALKXjjTes56SRpRYRh_FpYWNDV25Cmp5ixk84m6cL8e1tm3YsB16sQ8rxJeN5zwc784ImxlwgFAsq322JrrC04YFUAFiDlE7ZAIaq8FLU6YwtQpcgRanXOLmLcAoCssH7GznktOUehFuzyI_XmQG22GcLgTThk101MYbTJDT5bd4lCdhOMj9akXzTv1kNIzmY_TX9H2Tfa98bSjnx6zp52po_04n5dsh-fP91svuZX118uN-ur3EqAlHeADZKSJZaIQrYdVhUXwthGcSPazrTWQNVOZ62S9QpqbMuu4koY2agV1uWSvTneuw_D7Ugx6Z2LlvreeBrGqDlwXteiXOGEvj5Bt8MY_PS7mQKlSpzAJXt1T43Njlq9D243idB_JU0APwI2DDEG6h4QBD03obd6bkLPTWhAPTUxhaqTkHXJzFZTMK5_PPr-GKVJ452joKN15C21LpBNuh3c4_EPJ3HbO--s6X_TgeKDAtSRa9Df5ymZhwSrElYCZsPv_n3B_17_AzB_ydU |
CitedBy_id | crossref_primary_10_1016_j_jaccas_2023_101828 crossref_primary_10_3390_jcm13020592 crossref_primary_10_4244_EIJ_D_20_00475 crossref_primary_10_3349_ymj_2021_62_3_209 crossref_primary_10_1016_j_pcad_2020_04_002 crossref_primary_10_1016_j_amjcard_2023_07_137 crossref_primary_10_1007_s13239_021_00596_x crossref_primary_10_1016_j_jaccas_2024_103200 crossref_primary_10_1016_j_jcin_2023_01_381 crossref_primary_10_1016_j_jaccas_2019_06_034 crossref_primary_10_1186_s13019_024_02615_z crossref_primary_10_1016_j_jcin_2020_11_021 crossref_primary_10_1093_ehjcr_ytaa368 crossref_primary_10_1016_j_jcin_2019_04_052 crossref_primary_10_3390_jcm12165299 crossref_primary_10_1111_jocs_13976 crossref_primary_10_1002_ccd_29860 crossref_primary_10_1016_j_shj_2022_100032 crossref_primary_10_1016_j_jcin_2021_08_012 crossref_primary_10_4244_EIJV15I1A3 crossref_primary_10_3390_jcm12010338 crossref_primary_10_1016_j_jcin_2019_11_024 crossref_primary_10_1016_j_jcin_2019_11_027 crossref_primary_10_1093_eurheartj_ehaa799 crossref_primary_10_1161_JAHA_123_030328 crossref_primary_10_1016_j_jcin_2023_03_024 crossref_primary_10_7759_cureus_40514 crossref_primary_10_1016_j_jcin_2023_03_021 crossref_primary_10_33290_jtvt_cr_23_0001 crossref_primary_10_1016_j_ccl_2024_02_016 crossref_primary_10_1016_j_jccase_2021_06_012 crossref_primary_10_1016_j_iccl_2021_06_004 crossref_primary_10_1001_jamacardio_2020_3682 crossref_primary_10_1186_s13256_024_04806_7 crossref_primary_10_7759_cureus_29530 crossref_primary_10_1080_14779072_2020_1778465 crossref_primary_10_1016_j_ijcard_2021_12_044 crossref_primary_10_1016_j_jcin_2022_01_003 crossref_primary_10_1016_j_jcin_2024_01_289 crossref_primary_10_1016_j_jaccas_2019_07_017 crossref_primary_10_1161_CIRCIMAGING_121_012854 crossref_primary_10_7759_cureus_12373 crossref_primary_10_1093_ehjcr_ytac011 crossref_primary_10_3390_jcdd10050187 crossref_primary_10_1016_j_iccl_2021_05_004 crossref_primary_10_1097_JCMA_0000000000000187 crossref_primary_10_1016_j_carrev_2019_01_026 crossref_primary_10_3389_fcvm_2019_00120 crossref_primary_10_1002_ehf2_14319 crossref_primary_10_1016_j_jcin_2019_02_029 crossref_primary_10_1177_1556984519858020 crossref_primary_10_1161_CIRCINTERVENTIONS_122_012388 crossref_primary_10_1016_j_jcin_2020_01_201 crossref_primary_10_1016_j_jtcvs_2019_05_006 crossref_primary_10_3389_fcvm_2021_654554 crossref_primary_10_29328_journal_jccm_1001159 crossref_primary_10_1016_j_jcin_2021_08_076 crossref_primary_10_1093_ejcts_ezae056 crossref_primary_10_1016_j_pcad_2019_05_004 crossref_primary_10_1016_j_jacc_2021_02_038 crossref_primary_10_1161_CIRCINTERVENTIONS_123_012827 crossref_primary_10_3389_fcvm_2025_1529523 crossref_primary_10_1016_j_clinthera_2023_09_028 crossref_primary_10_1016_j_jcin_2023_01_013 crossref_primary_10_1002_ccd_29919 crossref_primary_10_1016_j_crad_2019_11_015 crossref_primary_10_1080_14779072_2020_1833717 crossref_primary_10_1093_ehjcr_ytae300 crossref_primary_10_1016_j_jscai_2022_100347 crossref_primary_10_1002_ccd_31394 crossref_primary_10_1016_j_crmic_2024_100039 crossref_primary_10_1161_CIRCINTERVENTIONS_121_011028 crossref_primary_10_1161_CIRCINTERVENTIONS_119_008044 crossref_primary_10_3390_jcdd9070223 crossref_primary_10_1016_j_jcin_2023_04_038 crossref_primary_10_1093_eurheartj_ehae606 crossref_primary_10_1136_heartjnl_2018_313517 crossref_primary_10_1016_j_ahj_2022_01_003 crossref_primary_10_1016_j_carrev_2020_06_032 crossref_primary_10_1016_j_jcin_2019_12_012 crossref_primary_10_1161_CIRCRESAHA_121_318040 crossref_primary_10_1016_j_carrev_2020_04_022 crossref_primary_10_1002_ccd_30377 crossref_primary_10_1016_j_amjcard_2021_01_028 crossref_primary_10_1093_ehjcr_ytaa443 crossref_primary_10_1093_ehjcr_ytab137 crossref_primary_10_1016_j_jcin_2020_01_229 crossref_primary_10_1093_ehjcr_ytaa207 crossref_primary_10_3389_fcvm_2018_00091 crossref_primary_10_3390_jcm13051297 crossref_primary_10_1016_j_carrev_2018_10_004 crossref_primary_10_4244_EIJ_D_19_00788 crossref_primary_10_1016_j_jcin_2024_01_299 crossref_primary_10_1016_j_amjcard_2023_02_003 crossref_primary_10_1186_s12872_021_02249_2 crossref_primary_10_1016_j_jcin_2020_10_031 crossref_primary_10_1016_j_jccase_2021_07_013 crossref_primary_10_4244_EIJ_D_22_00960 crossref_primary_10_1016_j_ccl_2019_09_013 crossref_primary_10_1016_j_jcin_2023_07_015 crossref_primary_10_1016_j_jaccas_2023_101992 crossref_primary_10_1093_ehjcr_ytaa288 crossref_primary_10_1016_j_carrev_2019_06_017 crossref_primary_10_1016_j_jcin_2020_01_217 crossref_primary_10_1016_j_carrev_2020_07_002 crossref_primary_10_1016_j_jcin_2020_01_216 crossref_primary_10_1016_j_jacc_2021_03_014 crossref_primary_10_1016_j_tcm_2020_10_002 crossref_primary_10_1016_j_cjca_2025_02_026 crossref_primary_10_1016_j_jcin_2023_04_020 crossref_primary_10_33290_jtvt_oa_22_0006 crossref_primary_10_1016_j_jcin_2021_02_035 crossref_primary_10_1016_j_jacc_2018_01_067 crossref_primary_10_26442_00403660_2020_04_000466 crossref_primary_10_1161_CIRCULATIONAHA_120_049693 crossref_primary_10_1002_ccd_29847 crossref_primary_10_4244_EIJ_D_18_00667 crossref_primary_10_1093_eurheartj_ehy893 crossref_primary_10_1536_ihj_20_401 crossref_primary_10_1111_jocs_16380 crossref_primary_10_1016_j_jjcc_2022_08_009 crossref_primary_10_1016_j_circv_2024_01_011 crossref_primary_10_1016_j_jcin_2019_03_035 crossref_primary_10_1186_s13256_018_1785_x crossref_primary_10_1136_openhrt_2022_002172 crossref_primary_10_3390_jcm11154445 crossref_primary_10_3389_fcvm_2019_00168 crossref_primary_10_1177_02184923211018041 crossref_primary_10_1016_j_ancard_2019_09_019 crossref_primary_10_1016_j_jccase_2023_10_008 crossref_primary_10_1016_j_carrev_2024_03_010 crossref_primary_10_1016_j_jcin_2024_01_007 crossref_primary_10_1016_j_ijscr_2024_110637 crossref_primary_10_1016_j_jeurea_2020_02_007 crossref_primary_10_1161_CIRCINTERVENTIONS_120_009017 crossref_primary_10_1016_j_carrev_2020_12_013 crossref_primary_10_4244_EIJV14I15A263 crossref_primary_10_1016_j_hlc_2019_04_009 crossref_primary_10_1016_j_ancard_2019_09_026 crossref_primary_10_1016_j_jcin_2022_10_050 crossref_primary_10_1016_j_jcin_2022_11_018 crossref_primary_10_4326_jjcvs_53_114 crossref_primary_10_18632_aging_102005 crossref_primary_10_1007_s11748_021_01693_3 crossref_primary_10_1016_j_jcin_2023_05_038 crossref_primary_10_1002_ccd_31197 crossref_primary_10_1016_j_jaccas_2019_08_011 crossref_primary_10_1016_j_ajem_2022_03_042 crossref_primary_10_1016_j_crad_2019_12_003 crossref_primary_10_1016_j_rec_2019_06_018 crossref_primary_10_1016_j_recesp_2019_06_010 crossref_primary_10_1016_j_carrev_2019_09_017 crossref_primary_10_3390_jcdd10080341 crossref_primary_10_1136_openhrt_2019_001132 crossref_primary_10_1080_08998280_2022_2158770 crossref_primary_10_1161_CIRCINTERVENTIONS_120_010238 |
Cites_doi | 10.1016/j.jcin.2016.08.015 10.1016/j.jcin.2014.01.173 10.1161/CIRCULATIONAHA.112.104505 10.7326/0003-4819-158-1-201301010-00007 10.1016/j.jcin.2017.06.047 10.1016/j.jcin.2016.09.034 10.14503/THIJ-13-3410 10.1016/j.jacc.2012.09.001 10.1510/icvts.2010.252866 10.1016/j.ijcard.2016.02.094 10.1016/j.jcin.2012.11.014 10.1093/eurheartj/ehx455 10.1161/CIRCULATIONAHA.113.002947 10.1161/CIRCINTERVENTIONS.115.003651 10.1016/j.jacc.2013.07.040 10.1001/jama.2014.7246 10.1161/CIRCULATIONAHA.116.025103 10.1001/jama.2016.12347 10.4137/CCRep.S40851 10.4244/EIJY14M11_06 10.1056/NEJMoa1514616 10.1016/j.jcin.2016.08.027 10.1016/j.cjca.2012.09.018 |
ContentType | Journal Article |
Copyright | 2018 Copyright © 2018. Published by Elsevier Inc. Copyright Elsevier Limited Apr 10, 2018 |
Copyright_xml | – notice: 2018 – notice: Copyright © 2018. Published by Elsevier Inc. – notice: Copyright Elsevier Limited Apr 10, 2018 |
DBID | 6I. AAFTH AAYXX CITATION NPM 7T5 7TK H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jacc.2018.01.066 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
EndPage | 1524 |
ExternalDocumentID | 29622157 10_1016_j_jacc_2018_01_066 S0735109718304509 1_s2_0_S0735109718304509 |
Genre | Journal Article |
GeographicLocations | Middle East North America Europe |
GeographicLocations_xml | – name: North America – name: Europe – name: Middle East |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AAEDT AAEDW AAIKJ AALRI AAOAW AAQFI AAQQT AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ACGFO ACGFS ACIUM ACJTP ACPRK ACVFH ADBBV ADCNI ADEZE ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRAH AFRHN AFTJW AGCQF AGYEJ AHMBA AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CS3 DIK DU5 E3Z EBS EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF IHE IXB J1W K-O KQ8 L7B MO0 N9A O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ Q38 ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R .55 .GJ 0SF 1CY 29L 3O- 3V. 6I. 7RV AACTN AAFTH AAKUH AAQXK AAYOK ABVKL ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFETI AFFNX AGHFR AJOXV AMFUW ASPBG AVWKF AZFZN BENPR BPHCQ FGOYB HX~ HZ~ J5H N4W NCXOZ PROAC QTD R2- RIG SEW T5K X7M XPP YYP ZGI ZXP AAIAV ABJNI EFLBG LCYCR NAHTW ZA5 AAYWO AAYXX AGQPQ CITATION NPM 7T5 7TK H94 K9. NAPCQ 7X8 ~HD |
ID | FETCH-LOGICAL-c600t-f01b1e763131156df188255acb72a5dfadca08d115d7694091d3f8275a6b74193 |
IEDL.DBID | .~1 |
ISSN | 0735-1097 1558-3597 |
IngestDate | Sun Sep 28 06:56:14 EDT 2025 Fri Jul 25 09:24:26 EDT 2025 Thu Apr 03 06:58:07 EDT 2025 Thu Apr 24 22:50:08 EDT 2025 Tue Jul 01 04:22:09 EDT 2025 Fri Feb 23 02:20:44 EST 2024 Sun Feb 23 10:19:01 EST 2025 Tue Aug 26 16:31:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | ViV TAVI LCA coronary obstruction TAVR CT DCO RCA PCI transcatheter aortic valve replacement STEMI SOV CABG computed tomography sinus of Valsalva left coronary artery right coronary artery percutaneous coronary intervention delayed coronary obstruction valve-in-valve ST-segment elevation myocardial infarction coronary artery bypass grafting |
Language | English |
License | This article is made available under the Elsevier license. Copyright © 2018. Published by Elsevier Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-f01b1e763131156df188255acb72a5dfadca08d115d7694091d3f8275a6b74193 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0735109718304509 |
PMID | 29622157 |
PQID | 2020773195 |
PQPubID | 2031078 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2022995341 proquest_journals_2020773195 pubmed_primary_29622157 crossref_primary_10_1016_j_jacc_2018_01_066 crossref_citationtrail_10_1016_j_jacc_2018_01_066 elsevier_sciencedirect_doi_10_1016_j_jacc_2018_01_066 elsevier_clinicalkeyesjournals_1_s2_0_S0735109718304509 elsevier_clinicalkey_doi_10_1016_j_jacc_2018_01_066 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-10 |
PublicationDateYYYYMMDD | 2018-04-10 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2018 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Kappetein, Head, Généreux (bib12) 2012; 60 Dvir, Webb, Bleiziffer (bib19) 2014; 312 Sondergaard (bib1) 2016; 9 Simonato, Webb, Kornowski (bib15) 2016; 9 Kukucka, Pasic, Dreysse, Hetzer (bib10) 2011; 12 Ribeiro, Webb, Makkar (bib5) 2013; 62 Regueiro, Linke, Latib (bib3) 2016; 316 Dvir, Webb, Brecker (bib18) 2012; 126 Sharma, Mascarenhas (bib23) 2016; 9 Leon, Smith, Mack (bib22) 2016; 374 Wendler, Schymik, Treede (bib21) 2017; 135 Rojas, Amat-Santos, Cortés (bib4) 2016; 9 Tarantini, Mojoli, Purita (bib14) 2015; 11 Ribeiro, Nombela-Franco, Urena (bib16) 2013; 6 Jabbour, Pagnesi, Kawamoto (bib2) 2016; 210 Neuss, Kaneko, Tambor, Hoelschermann, Butter (bib11) 2016; 9 Khatri, Webb, Rodés-Cabau (bib17) 2013; 158 Freixa, Bonan, Asgar (bib9) 2013; 29 Ribeiro, Rodés-Cabau, Blanke (bib20) 2018; 39 Spaziano, Akodad, Hovasse, Lefèvre, Bouvier, Chevalier (bib24) 2017; 10 Durmaz, Ayhan, Keles (bib6) 2014; 41 Giustino, Montorfano, Chieffo (bib7) 2014; 7 Jategaonkar, Dimitriadis, Hakim-Meibodi, Gummert, Horstkotte, Scholtz (bib8) 2013; 22 Barbanti, Yang, Rodès Cabau (bib13) 2013; 128 Spaziano (10.1016/j.jacc.2018.01.066_bib24) 2017; 10 Rojas (10.1016/j.jacc.2018.01.066_bib4) 2016; 9 Dvir (10.1016/j.jacc.2018.01.066_bib19) 2014; 312 Jabbour (10.1016/j.jacc.2018.01.066_bib2) 2016; 210 Tarantini (10.1016/j.jacc.2018.01.066_bib14) 2015; 11 Sharma (10.1016/j.jacc.2018.01.066_bib23) 2016; 9 Leon (10.1016/j.jacc.2018.01.066_bib22) 2016; 374 Barbanti (10.1016/j.jacc.2018.01.066_bib13) 2013; 128 Sondergaard (10.1016/j.jacc.2018.01.066_bib1) 2016; 9 Kappetein (10.1016/j.jacc.2018.01.066_bib12) 2012; 60 Simonato (10.1016/j.jacc.2018.01.066_bib15) 2016; 9 Ribeiro (10.1016/j.jacc.2018.01.066_bib20) 2018; 39 Freixa (10.1016/j.jacc.2018.01.066_bib9) 2013; 29 Neuss (10.1016/j.jacc.2018.01.066_bib11) 2016; 9 Giustino (10.1016/j.jacc.2018.01.066_bib7) 2014; 7 Regueiro (10.1016/j.jacc.2018.01.066_bib3) 2016; 316 Durmaz (10.1016/j.jacc.2018.01.066_bib6) 2014; 41 Kukucka (10.1016/j.jacc.2018.01.066_bib10) 2011; 12 Jategaonkar (10.1016/j.jacc.2018.01.066_bib8) 2013; 22 Ribeiro (10.1016/j.jacc.2018.01.066_bib16) 2013; 6 Dvir (10.1016/j.jacc.2018.01.066_bib18) 2012; 126 Khatri (10.1016/j.jacc.2018.01.066_bib17) 2013; 158 Wendler (10.1016/j.jacc.2018.01.066_bib21) 2017; 135 Ribeiro (10.1016/j.jacc.2018.01.066_bib5) 2013; 62 29622158 - J Am Coll Cardiol. 2018 Apr 10;71(14):1525-1527 |
References_xml | – volume: 41 start-page: 414 year: 2014 end-page: 417 ident: bib6 article-title: Left main coronary artery obstruction by dislodged native-valve calculus after transcatheter aortic valve replacement publication-title: Tex Heart Inst J – volume: 374 start-page: 1609 year: 2016 end-page: 1620 ident: bib22 article-title: Transcatheter or surgical aortic-valve replacement in intermediate-risk patients publication-title: N Engl J Med – volume: 9 start-page: 2183 year: 2016 end-page: 2185 ident: bib1 article-title: Time to explore transcatheter aortic valve replacement in younger, low-risk patients publication-title: J Am Coll Cardiol Intv – volume: 12 start-page: 57 year: 2011 end-page: 60 ident: bib10 article-title: Delayed subtotal coronary obstruction after transapical aortic valve implantation publication-title: Interact Cardiovasc Thorac Surg – volume: 158 start-page: 35 year: 2013 end-page: 46 ident: bib17 article-title: Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies publication-title: Ann Intern Med – volume: 7 start-page: e105 year: 2014 end-page: e107 ident: bib7 article-title: Tardive coronary obstruction by a native leaflet after transcatheter aortic valve replacement in a patient with heavily calcified aortic valve stenosis publication-title: J Am Coll Cardiol Intv – volume: 10 start-page: e185 year: 2017 end-page: e187 ident: bib24 article-title: Simultaneous TAVR and left main “chimney” stenting in a patient with low left main height publication-title: J Am Coll Cardiol Intv – volume: 9 start-page: 2257 year: 2016 end-page: 2258 ident: bib11 article-title: Fatal thrombotic occlusion of left main trunk due to huge thrombus on prosthetic aortic valve after transcatheter aortic valve replacement publication-title: J Am Coll Cardiol Intv – volume: 62 start-page: 1552 year: 2013 end-page: 1562 ident: bib5 article-title: Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry publication-title: J Am Coll Cardiol – volume: 210 start-page: 35 year: 2016 end-page: 37 ident: bib2 article-title: Transcatheter aortic valve implantation in intermediate- and low-risk populations: an inevitable progression? publication-title: Int J Cardiol – volume: 29 start-page: 1014 year: 2013 ident: bib9 article-title: Unusual coronary occlusion post transcatheter aortic implantation: the importance of clinical assessment publication-title: Can J Cardiol – volume: 60 start-page: 1438 year: 2012 end-page: 1454 ident: bib12 article-title: Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document publication-title: J Am Coll Cardiol – volume: 316 start-page: 1083 year: 2016 end-page: 1092 ident: bib3 article-title: Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death publication-title: JAMA – volume: 126 start-page: 2335 year: 2012 end-page: 2344 ident: bib18 article-title: Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry publication-title: Circulation – volume: 9 start-page: 2527 year: 2016 end-page: 2538 ident: bib4 article-title: Acquired aseptic intracardiac shunts following transcatheter aortic valve replacement: a systematic review publication-title: JACC Cardiovasc Interv – volume: 22 start-page: 762 year: 2013 end-page: 766 ident: bib8 article-title: Delayed coronary ischemia after transfemoral aortic valve implantation publication-title: J Heart Valve Dis – volume: 11 start-page: 343 year: 2015 end-page: 350 ident: bib14 article-title: Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve publication-title: EuroIntervention – volume: 312 start-page: 162 year: 2014 end-page: 170 ident: bib19 article-title: Transcatheter aortic valve implantation in failed bioprosthetic surgical valves publication-title: JAMA – volume: 39 start-page: 687 year: 2018 end-page: 695 ident: bib20 article-title: Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry publication-title: Eur Heart J – volume: 128 start-page: 244 year: 2013 end-page: 253 ident: bib13 article-title: Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement publication-title: Circulation – volume: 9 start-page: e003651 year: 2016 ident: bib15 article-title: Transcatheter replacement of failed bioprosthetic valves: large multicenter assessment of the effect of implantation depth on hemodynamics after aortic valve-in-valve publication-title: Circ Cardiovasc Interv – volume: 6 start-page: 452 year: 2013 end-page: 461 ident: bib16 article-title: Coronary obstruction following transcatheter aortic valve implantation: a systematic review publication-title: J Am Coll Cardiol Intv – volume: 9 start-page: 111 year: 2016 end-page: 113 ident: bib23 article-title: Left main coronary ostial stenosis after aortic valve replacement: a case report publication-title: Clin Med Insights Case Rep – volume: 135 start-page: 1123 year: 2017 end-page: 1132 ident: bib21 article-title: SOURCE 3 Registry: design and 30-day results of the European Post Approval Registry of the Latest Generation of the Sapien 3TM Transcatheter Heart Valve publication-title: Circulation – volume: 9 start-page: 2183 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib1 article-title: Time to explore transcatheter aortic valve replacement in younger, low-risk patients publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2016.08.015 – volume: 7 start-page: e105 year: 2014 ident: 10.1016/j.jacc.2018.01.066_bib7 article-title: Tardive coronary obstruction by a native leaflet after transcatheter aortic valve replacement in a patient with heavily calcified aortic valve stenosis publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2014.01.173 – volume: 22 start-page: 762 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib8 article-title: Delayed coronary ischemia after transfemoral aortic valve implantation publication-title: J Heart Valve Dis – volume: 126 start-page: 2335 year: 2012 ident: 10.1016/j.jacc.2018.01.066_bib18 article-title: Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.104505 – volume: 158 start-page: 35 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib17 article-title: Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies publication-title: Ann Intern Med doi: 10.7326/0003-4819-158-1-201301010-00007 – volume: 10 start-page: e185 year: 2017 ident: 10.1016/j.jacc.2018.01.066_bib24 article-title: Simultaneous TAVR and left main “chimney” stenting in a patient with low left main height publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2017.06.047 – volume: 9 start-page: 2527 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib4 article-title: Acquired aseptic intracardiac shunts following transcatheter aortic valve replacement: a systematic review publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2016.09.034 – volume: 41 start-page: 414 year: 2014 ident: 10.1016/j.jacc.2018.01.066_bib6 article-title: Left main coronary artery obstruction by dislodged native-valve calculus after transcatheter aortic valve replacement publication-title: Tex Heart Inst J doi: 10.14503/THIJ-13-3410 – volume: 60 start-page: 1438 year: 2012 ident: 10.1016/j.jacc.2018.01.066_bib12 article-title: Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.09.001 – volume: 12 start-page: 57 year: 2011 ident: 10.1016/j.jacc.2018.01.066_bib10 article-title: Delayed subtotal coronary obstruction after transapical aortic valve implantation publication-title: Interact Cardiovasc Thorac Surg doi: 10.1510/icvts.2010.252866 – volume: 210 start-page: 35 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib2 article-title: Transcatheter aortic valve implantation in intermediate- and low-risk populations: an inevitable progression? publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.02.094 – volume: 6 start-page: 452 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib16 article-title: Coronary obstruction following transcatheter aortic valve implantation: a systematic review publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2012.11.014 – volume: 39 start-page: 687 year: 2018 ident: 10.1016/j.jacc.2018.01.066_bib20 article-title: Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx455 – volume: 128 start-page: 244 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib13 article-title: Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.002947 – volume: 9 start-page: e003651 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib15 article-title: Transcatheter replacement of failed bioprosthetic valves: large multicenter assessment of the effect of implantation depth on hemodynamics after aortic valve-in-valve publication-title: Circ Cardiovasc Interv doi: 10.1161/CIRCINTERVENTIONS.115.003651 – volume: 62 start-page: 1552 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib5 article-title: Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.07.040 – volume: 312 start-page: 162 year: 2014 ident: 10.1016/j.jacc.2018.01.066_bib19 article-title: Transcatheter aortic valve implantation in failed bioprosthetic surgical valves publication-title: JAMA doi: 10.1001/jama.2014.7246 – volume: 135 start-page: 1123 year: 2017 ident: 10.1016/j.jacc.2018.01.066_bib21 article-title: SOURCE 3 Registry: design and 30-day results of the European Post Approval Registry of the Latest Generation of the Sapien 3TM Transcatheter Heart Valve publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.025103 – volume: 316 start-page: 1083 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib3 article-title: Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death publication-title: JAMA doi: 10.1001/jama.2016.12347 – volume: 9 start-page: 111 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib23 article-title: Left main coronary ostial stenosis after aortic valve replacement: a case report publication-title: Clin Med Insights Case Rep doi: 10.4137/CCRep.S40851 – volume: 11 start-page: 343 year: 2015 ident: 10.1016/j.jacc.2018.01.066_bib14 article-title: Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve publication-title: EuroIntervention doi: 10.4244/EIJY14M11_06 – volume: 374 start-page: 1609 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib22 article-title: Transcatheter or surgical aortic-valve replacement in intermediate-risk patients publication-title: N Engl J Med doi: 10.1056/NEJMoa1514616 – volume: 9 start-page: 2257 year: 2016 ident: 10.1016/j.jacc.2018.01.066_bib11 article-title: Fatal thrombotic occlusion of left main trunk due to huge thrombus on prosthetic aortic valve after transcatheter aortic valve replacement publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2016.08.027 – volume: 29 start-page: 1014 year: 2013 ident: 10.1016/j.jacc.2018.01.066_bib9 article-title: Unusual coronary occlusion post transcatheter aortic implantation: the importance of clinical assessment publication-title: Can J Cardiol doi: 10.1016/j.cjca.2012.09.018 – reference: 29622158 - J Am Coll Cardiol. 2018 Apr 10;71(14):1525-1527 |
SSID | ssj0006819 |
Score | 2.6119785 |
Snippet | Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).
The aim of this... AbstractBackgroundDelayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).... BackgroundDelayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement... Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).BACKGROUNDDelayed... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1513 |
SubjectTerms | Angina pectoris Angiography Aortic valve Balloon treatment Calcification Cardiology Cardiovascular Cardiovascular disease Coronary artery coronary obstruction Coronary vessels Heart diseases Implants Medical imaging Myocardial infarction Patients Stents TAVI TAVR transcatheter aortic valve replacement |
Title | Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0735109718304509 https://www.clinicalkey.es/playcontent/1-s2.0-S0735109718304509 https://dx.doi.org/10.1016/j.jacc.2018.01.066 https://www.ncbi.nlm.nih.gov/pubmed/29622157 https://www.proquest.com/docview/2020773195 https://www.proquest.com/docview/2022995341 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFH5CHBAXxGBAGKBM2g2Fxk4cN8eugNpJ3Q78UG-WHTsSqGoRhUlc9rfvPccJmgadtEskx3ZsvTw_f7afvwfwhWdSiqrMkpJzXKA4YRJTlyyxttBVrk2mfSyCyfdidJN_m4rpGgzbuzDkVhlsf2PTvbUOb3pBmr2Hu7veFSqnoPNTVErEJf4SX55L0vWzX69uHkXfB_egwgmVDhdnGh-ve10RjSHre-pOz5T45uT0Hvj0k9DlNmwF9BgPmg5-gDU334GNSTgf34XxuZvpF2fjIRET6MeX-IfpGGLjAcUDj_3s5NlaKTVY0LfiWz376WJE47SrThuGH-Hm8uJ6OEpCsISkQszylNQpM8yhtfD8OYWtGWJnIXRlJNfC1tpWOu1bzLOyKHFVx2xW97kUujCIKspsD9bni7k7gFjqLC9r2hIqMkRTqcF_USNQytM6taXmEbBWSqoKTOIU0GKmWpexe0WSVSRZlTKFko3gtKvz0PBorCydtcJX7Q1RtGkKzfzKWvKtWm4ZhuVSMbXkKlV_qU4Eoqv5h_b9s8WjVjNU1whHBC4lmjYRwecuG0ctHcXouVs8-zKIAwRCiAj2G43qxMLLAseNkIf_2alPsEkpOvJi6RGso5a5Y0ROT-bEDw18jqdffwOsQhNb |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB6tQGp7qUrpI3ShqcStSjd24nhzXC2g5bFwACpulh07Emi1i7oUiUt_e2ccJxXiJfWY2I6tyefx59c3ANs8k1JUZZaUnOMExQmTmLpkibWFrnJtMu1jEUyPi8l5fnAhLnowbu_C0LHK4Psbn-69dXgzCNYcXF9eDk4RnIL2TxGUyEvoEt9qTohCUP_48--cRzH00T0od0LZw82Z5pDXla5Ix5ANvXanl0p8dHR6in36UWjvHbwN9DEeNS1cg56bv4dX07BBvg77O26m75yNx6RMoH_dxSemk4iNRxQQPPbDk5drpafRgr4V_9SzWxcjHadldVox_ADne7tn40kSoiUkFZKWm6ROmWEO3YUX0ClszZA8C6ErI7kWtta20unQYpqVRYnTOmazesil0IVBWlFmH2Flvpi7zxBLneVlTWtCRYZ0KjX4M2pkSnlap7bUPALWWklVQUqcIlrMVHtm7EqRZRVZVqVMoWUj-N6VuW6ENJ7NnbXGV-0VUXRqCv38s6XkY6XcMvTLpWJqyVWqHmAnAtGVvAe_F2vst8hQXSUcKbiUiEQRwbcuGbst7cXouVv89nmQCAjkEBF8ahDVmYWXBXYcITf-s1Ff4fXkbHqkjvaPD7_AG0qh_S-W9mEFEec2kUbdmC3fTf4CBR0Vdg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Delayed+Coronary+Obstruction+After+Transcatheter+Aortic+Valve+Replacement&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Jabbour%2C+Richard+J&rft.au=Tanaka%2C+Akihito&rft.au=Finkelstein%2C+Ariel&rft.au=Mack%2C+Michael&rft.date=2018-04-10&rft.issn=1558-3597&rft.eissn=1558-3597&rft.volume=71&rft.issue=14&rft.spage=1513&rft_id=info:doi/10.1016%2Fj.jacc.2018.01.066&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109717X00193%2Fcov150h.gif |